Healthcare Takes A Big Step Forward With The Help of A.I.

To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.

Click here to learn more about the booming eHealth industry - and see which microcap will be at the

AKBA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $300,597.66

Akebia Therapeutics Insider Trading History Chart

Akebia Therapeutics Share Price & Price History

^$1.88

▲ +0.005 (0.27%)

As of 12/18/2024 02:40 PM ET

Days: 30 | 90 | 365

This Crypto Is Set to Explode in December

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

Akebia Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/29/2024	John P. Butler	CEO	Sell	46,570	$1.58	$73,580.60	2,044,580
2/29/2024	Michel Dahan	COO	Sell	8,661	$1.58	$13,684.38	706,932
2/29/2024	Nicole R Hadas	SVP	Sell	5,974	$1.58	$9,438.92	663,259
2/27/2024	John P. Butler	CEO	Sell	37,733	$1.52	$57,354.16	2,091,150
2/27/2024	Michel Dahan	COO	Sell	10,744	$1.52	$16,330.88	715,593
2/27/2024	Nicole R Hadas	SVP	Sell	7,411	$1.52	$11,264.72	669,233
2/1/2024	John P. Butler	CEO	Sell	46,489	$1.68	$78,101.52	2,128,883
2/1/2024	Steven Keith Burke	SVP	Sell	24,311	$1.68	$40,842.48	711,376
5/25/2023	Michel Dahan	COO	Sell	95,478	$1.22	$116,483.16	574,037
5/25/2023	Nicole R Hadas	SVP	Sell	63,186	$1.22	$77,086.92	524,344
5/16/2023	Steven Keith Burke	SVP	Sell	63,567	$1.07	$68,016.69	530,487
3/1/2023	David A. Spellman	CFO	Sell	7,210	$0.88	$6,344.80	510,050
3/1/2023	John P. Butler	CEO	Sell	91,868	$0.88	$80,843.84	1,568,872
3/1/2023	Michel Dahan	COO	Sell	20,412	$0.88	$17,962.56	269,515
3/1/2023	Nicole R Hadas	SVP	Sell	13,034	$0.88	$11,469.92	287,530
6/3/2022	Steven C Gilman	Director	Sell	4,567	$0.36	$1,644.12	43,430
3/1/2022	David A. Spellman	CFO	Sell	803	$2.17	$1,742.51
2/28/2022	John P. Butler	CEO	Sell	25,053	$2.15	$53,863.95
2/28/2022	Michel Dahan	COO	Sell	6,555	$2.15	$14,093.25
2/28/2022	Steven Keith Burke	SVP	Sell	7,400	$2.15	$15,910.00
2/28/2022	Violetta Cotreau	CAO	Sell	3,946	$2.15	$8,483.90

This drone stock is setting up to transform medical supply delivery

From The Tomorrow Investor | Ad

Drone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.

Click here to see how a new partnership could catapult this drone suppliers' growth

SEC Filings (Institutional Ownership Changes) for Akebia Therapeutics (NASDAQ:AKBA)

33.92% of Akebia Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Akebia Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/27/2024	Franklin Resources Inc.	167,184	$0.22M	0.0%	N/A	0.077%
11/20/2024	Virtu Financial LLC	55,746	$74K	0.0%	-25.8%	0.026%
11/19/2024	Barclays PLC	273,085	$0.36M	0.0%	+276.1%	0.125%
11/16/2024	Geode Capital Management LLC	4,754,464	$6.28M	0.0%	+4.8%	2.179%
11/15/2024	Barclays PLC	273,085	$0.36M	0.0%	+276.1%	0.125%
11/15/2024	XTX Topco Ltd	44,267	$58K	0.0%	N/A	0.020%
11/15/2024	Jane Street Group LLC	123,728	$0.16M	0.0%	-14.0%	0.057%
11/15/2024	Wellington Management Group LLP	404,718	$0.53M	0.0%	N/A	0.185%
11/15/2024	State Street Corp	3,430,527	$4.53M	0.0%	+24.9%	1.572%
11/15/2024	Jacobs Levy Equity Management Inc.	2,034,169	$2.69M	0.0%	-2.9%	0.932%
11/14/2024	MetLife Investment Management LLC	68,064	$90K	0.0%	+25.7%	0.031%
11/13/2024	BNP Paribas Financial Markets	46,270	$61K	0.0%	+205.8%	0.021%
11/13/2024	FMR LLC	682,038	$0.90M	0.0%	+26.0%	0.313%
11/13/2024	The Manufacturers Life Insurance Company	78,444	$0.10M	0.0%	N/A	0.036%
11/9/2024	Intech Investment Management LLC	45,066	$59K	0.0%	N/A	0.021%
11/1/2024	CWA Asset Management Group LLC	49,000	$65K	0.0%	N/A	0.023%
10/11/2024	Empirical Asset Management LLC	33,700	$44K	0.0%	N/A	0.016%
10/3/2024	SG Americas Securities LLC	71,965	$95K	0.0%	+117.1%	0.034%
8/19/2024	B. Riley Wealth Advisors Inc.	43,360	$44K	0.0%	N/A	0.021%
8/15/2024	Alerce Investment Management L.P.	5,747,906	$5.86M	11.5%	-56.5%	2.742%
8/14/2024	Marshall Wace LLP	247,069	$0.25M	0.0%	-75.9%	0.118%
8/13/2024	Orchard Capital Management LLC	86,826	$89K	0.0%	-19.9%	0.041%
8/12/2024	Marathon Trading Investment Management LLC	52,651	$54K	0.0%	-79.7%	0.025%
8/12/2024	Mercer Global Advisors Inc. ADV	31,221	$32K	0.0%	+40.7%	0.015%
8/9/2024	Renaissance Technologies LLC	3,914,800	$3.99M	0.0%	+7.2%	1.868%
8/6/2024	Acadian Asset Management LLC	4,063,383	$4.14M	0.0%	-23.5%	1.939%
8/1/2024	Rhumbline Advisers	247,060	$0.25M	0.0%	+4,915.4%	0.118%
7/26/2024	Bank of New York Mellon Corp	604,551	$0.62M	0.0%	+3,122.2%	0.288%
7/18/2024	Assenagon Asset Management S.A.	211,647	$0.22M	0.0%	-73.2%	0.101%
7/12/2024	SG Americas Securities LLC	33,144	$34K	0.0%	N/A	0.016%
5/16/2024	Jacobs Levy Equity Management Inc.	1,637,578	$3M	0.0%	-11.8%	0.781%
5/15/2024	Lazard Asset Management LLC	43,545	$79K	0.0%	N/A	0.021%
5/10/2024	Acadian Asset Management LLC	5,309,755	$9.72M	0.0%	-23.2%	2.536%
5/10/2024	Vanguard Group Inc.	8,225,972	$15.05M	0.0%	+8.1%	3.929%
4/24/2024	Assenagon Asset Management S.A.	790,483	$1.45M	0.0%	N/A	0.378%
4/18/2024	Compass Ion Advisors LLC	25,095	$46K	0.0%	N/A	0.012%
4/17/2024	Cannon Global Investment Management LLC	28,000	$51K	0.1%	N/A	0.013%
2/15/2024	Orchard Capital Management LLC	86,826	$0.11M	0.0%	+29.9%	0.044%
2/6/2024	Sapient Capital LLC	200,000	$0.25M	0.0%	N/A	0.101%
2/5/2024	Victory Capital Management Inc.	22,519	$28K	0.0%	-97.0%	0.011%
2/5/2024	Eagle Wealth Strategies LLC	20,017	$25K	0.0%	N/A	0.010%
1/31/2024	Federated Hermes Inc.	866,554	$1.08M	0.0%	-10.2%	0.460%
1/31/2024	Archer Investment Corp	19,800	$25K	0.0%	N/A	0.011%
1/30/2024	Mackenzie Financial Corp	23,159	$29K	0.0%	+37.6%	0.012%
1/29/2024	Sapient Capital LLC	200,000	$0.25M	0.0%	N/A	0.106%
1/16/2024	Raymond James & Associates	29,917	$37K	0.0%	+48.0%	0.016%
12/6/2023	Citigroup Inc.	152,737	$0.17M	0.0%	+311,608.2%	0.081%
11/13/2023	Acadian Asset Management LLC	7,223,488	$8.23M	0.0%	-3.2%	3.834%
11/6/2023	Victory Capital Management Inc.	755,488	$0.86M	0.0%	+14.1%	0.401%
8/7/2023	Acadian Asset Management LLC	7,460,353	$6.82M	0.0%	-0.3%	4.012%
8/3/2023	Mackenzie Financial Corp	27,199	$25K	0.0%	-34.3%	0.015%
7/27/2023	Victory Capital Management Inc.	661,898	$0.61M	0.0%	+156.8%	0.356%
7/27/2023	Virtu Financial LLC	50,633	$46K	0.0%	-48.3%	0.027%
7/27/2023	CWA Asset Management Group LLC	49,000	$45K	0.0%	+69.0%	0.026%
7/19/2023	Eudaimonia Partners LLC	27,144	$25K	0.0%	+123.5%	0.015%
5/15/2023	Alerce Investment Management L.P.	16,205,119	$9.08M	12.0%	+7.4%	8.716%
5/12/2023	Mirabella Financial Services LLP	140,604	$1.83M	0.3%	N/A	0.076%
5/11/2023	Icon Wealth Partners LLC	50,000	$28K	0.0%	N/A	0.027%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	302,977	$0.17M	0.0%	+152.4%	0.163%
5/2/2023	Victory Capital Management Inc.	257,744	$0.14M	0.0%	+1,200.3%	0.140%
5/1/2023	Virtu Financial LLC	97,854	$55K	0.0%	N/A	0.053%
2/15/2023	Alerce Investment Management L.P.	15,090,119	$8.71M	10.0%	+224.3%	8.203%
2/10/2023	Orchard Capital Management LLC	66,826	$39K	0.0%	-73.5%	0.036%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	120,053	$69K	0.0%	-76.5%	0.065%
11/14/2022	Ergoteles LLC	165,237	$52K	0.0%	-80.5%	0.090%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	510,102	$0.16M	0.0%	+124.9%	0.277%
10/26/2022	Allspring Global Investments Holdings LLC	242,866	$76K	0.0%	+43.8%	0.132%
10/26/2022	Wipfli Financial Advisors LLC	200,000	$63K	0.0%	N/A	0.109%
9/16/2022	Federated Hermes Inc.	1,989,467	$0.70M	0.0%	-2.0%	1.082%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	226,770	$80K	0.0%	-51.9%	0.124%
7/29/2022	Russell Investments Group Ltd.	225,640	$78K	0.0%	-11.8%	0.123%
7/25/2022	Allspring Global Investments Holdings LLC	168,942	$59K	0.0%	-51.7%	0.092%
7/19/2022	Icon Wealth Partners LLC	400,132	$0.14M	0.0%	N/A	0.218%
5/16/2022	Orchard Capital Managment LLC	1,762,731	$1.27M	0.4%	+10.6%	0.960%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	471,681	$0.34M	0.0%	+17.2%	0.257%
5/11/2022	GSA Capital Partners LLP	54,370	$39K	0.0%	N/A	0.030%
5/5/2022	Rice Hall James & Associates LLC	513,292	$0.37M	0.0%	+5.6%	0.280%
5/5/2022	Russell Investments Group Ltd.	255,967	$0.18M	0.0%	-19.0%	0.139%
4/25/2022	Assenagon Asset Management S.A.	104,092	$75K	0.0%	N/A	0.059%
2/19/2022	Woodline Partners LP	2,231,966	$5.04M	0.1%	-3.9%	1.276%
2/15/2022	Kennedy Capital Management Inc.	333,841	$0.75M	0.0%	-9.3%	0.191%
2/15/2022	Marshall Wace LLP	4,475,138	$10.11M	0.0%	-35.8%	2.558%
2/14/2022	PDT Partners LLC	433,400	$0.98M	0.1%	-25.5%	0.248%
2/14/2022	Virtus ETF Advisers LLC	69,015	$0.16M	0.1%	+18.5%	0.039%
2/14/2022	Point72 Hong Kong Ltd	13,106	$30K	0.0%	N/A	0.007%
2/14/2022	Rice Hall James & Associates LLC	486,220	$1.10M	0.0%	-14.1%	0.278%
2/14/2022	Blair William & Co. IL	16,599	$38K	0.0%	-27.5%	0.009%
2/10/2022	JPMorgan Chase & Co.	4,432,203	$10.02M	0.0%	-2.9%	2.533%
2/10/2022	Rafferty Asset Management LLC	738,075	$1.67M	0.0%	+9.5%	0.422%
2/10/2022	Teacher Retirement System of Texas	32,286	$73K	0.0%	+37.2%	0.018%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	402,416	$0.91M	0.0%	-6.6%	0.230%
2/9/2022	Principal Financial Group Inc.	258,563	$0.58M	0.0%	-52.1%	0.148%
2/9/2022	BNP Paribas Arbitrage SA	70,923	$0.16M	0.0%	-9.1%	0.041%
2/9/2022	Dimensional Fund Advisors LP	2,593,841	$5.86M	0.0%	+23.8%	1.483%
2/8/2022	Swiss National Bank	364,785	$0.82M	0.0%	+8.5%	0.208%
2/8/2022	Northern Trust Corp	1,746,054	$3.95M	0.0%	-1.5%	0.998%
2/7/2022	SG Americas Securities LLC	43,176	$98K	0.0%	-61.2%	0.025%
2/3/2022	Virginia Retirement Systems ET AL	111,800	$0.25M	0.0%	-29.6%	0.064%
2/3/2022	Nisa Investment Advisors LLC	356,208	$0.71M	0.0%	-1.7%	0.204%
2/2/2022	New York State Common Retirement Fund	123,867	$0.28M	0.0%	+42.9%	0.071%

Data available starting January 2016

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients. It offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. The company's product pipeline includes AKB-9090, a drug targeting critical-care indications; and AKB-10108, a drug targeting conditions related to premature birth. It has collaboration agreements with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $1.88

$1.86

$1.90

50 Day Range

MA: $1.77

$1.28

$2.13

52 Week Range

Now: $1.88

$0.80

$2.48

Volume

968,470 shs

Average Volume

3,010,952 shs

Market Capitalization

$409.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.7

Who are the company insiders with the largest holdings of Akebia Therapeutics?: Akebia Therapeutics' top insider shareholders include:
John P Butler (CEO)
Michel Dahan (COO)
Steven Keith Burke (SVP)
Nicole R Hadas (SVP)
David A Spellman (CFO)
Learn More about top insider investors at Akebia Therapeutics.
Who are the major institutional investors of Akebia Therapeutics?: Akebia Therapeutics' top institutional investors include:
Geode Capital Management LLC — 2.18%
State Street Corp — 1.57%
Jacobs Levy Equity Management Inc. — 0.93%
FMR LLC — 0.31%
Wellington Management Group LLP — 0.19%
Barclays PLC — 0.13%
Learn More about top institutional investors of Akebia Therapeutics stock.
Which institutional investors are selling Akebia Therapeutics stock?: Within the last quarter, AKBA stock was sold by these institutional investors:
Jacobs Levy Equity Management Inc.
Jane Street Group LLC
Virtu Financial LLC
Within the last year, company insiders that have sold Akebia Therapeutics company stock include:
John P Butler (CEO)
Michel Dahan (COO)
Steven Keith Burke (SVP)
Nicole R Hadas (SVP)
Learn More investors selling Akebia Therapeutics stock.
Which institutional investors are buying Akebia Therapeutics stock?: Within the previous quarter, AKBA stock was acquired by institutional investors including:
State Street Corp
Wellington Management Group LLP
Geode Capital Management LLC
Barclays PLC
Barclays PLC
Franklin Resources Inc.
FMR LLC
The Manufacturers Life Insurance Company